Keystone Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Wayland, MA and active since 1995.
Keystone Pharmaceuticals was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Anupauma Bhagat at the company’s single location by writing to 29 Three Ponds Road, Wayland, Massachusetts MA 01778 or by phoning (508) 358-3438. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Keystone Pharmaceuticals |
Contact Person: | Anupauma Bhagat |
Address: | 29 Three Ponds Road, Wayland, Massachusetts 01778 |
Phone Number: | (508) 358-3438 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1995 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Keystone Pharmaceuticals was started in 1995 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Anupauma Bhagat for inquiries that concern Keystone Pharmaceuticals by calling the company number (508) 358-3438, as your correspondence is most welcome. Additionally, the physical location of the single location of Keystone Pharmaceuticals can be found at the coordinates 42.376543,-71.348548 as well as the street address 29 Three Ponds Road in Wayland, Massachusetts 01778.
For its online presence, you may visit Keystone Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.